news
European Antibody Congress 2015 comes to Basel
18 August 2015 | By The European Antibody Congress
The European Antibody Congress takes place 9-11 November 2015 at the Congress Centre, Basel...
List view / Grid view
Ebola
news
CLR01 targets HIV and prevents semen from promoting infection
18 August 2015 | By Victoria White
Researchers have discovered a small molecule, known as CLR01, that attacks the HIV virus and disrupts the amyloids in semen that promote HIV infection...
news
Global vaccine-development fund could save thousands of lives
4 August 2015 | By Victoria White
For vaccine development, financial barriers persist: pharma companies see high costs with limited market potential, and government support is lacking...
news
Inovio’s DNA-based monoclonal antibody (dMAb) protects against dengue
30 July 2015 | By Victoria White
Inovio’s DNA-based monoclonal antibody (dMAb) targeting dengue virus provided protection against a lethal dengue virus challenge in mice...
news
Emergent awarded $19.7 million BARDA contract to develop Ebola monoclonal antibodies
21 July 2015 | By Victoria White
Emergent BioSolutions has been awarded a BARDA contract valued at $19.7 million to develop and manufacture three Ebola monoclonal antibodies...
news
Regeneron’s Veloci-technologies used to develop human antibodies in the fight against MERS
30 June 2015 | By Victoria White
A study has demonstrated that Veloci-technologies enabled rapid identification and validation of potential candidates that could be developed to treat MERS...
news
Researchers find new antibodies that protect against Marburg virus
29 June 2015 | By Victoria White
A study led by scientists at The Scripps Research Institute has identified new immune molecules that protect against Marburg virus, a relative of Ebola...
news
A close-up view of the Ebola virus life cycle
26 June 2015 | By Victoria White
A new study by scientists from the Scripps Research Institute reveals a key part of the Ebola virus life cycle at a higher resolution than ever before...
news
Ebola virus mutated slower than first thought
18 June 2015 | By Victoria White
The Ebola virus responsible for the outbreak in West Africa mutated at a similar rate to previous outbreaks, according to a new study led by PHE...
news
Inovio partners with GeneOne Life Science for MERS vaccine clinical development
3 June 2015 | By Victoria White
Inovio has said it will advance its DNA vaccine for MERS into a Phase I clinical trial in healthy volunteers in a collaboration with GeneOne Life Science...
news
Anti-Ebola MVA vaccine produced on ProBioGen’s AGE1.CR cell line platform enters clinical trials
3 June 2015 | By Victoria White
An investigational vaccine against Ebola, produced on ProBioGen’s proprietary, continuous muscovy duck AGE1.CR cell line, has proceeded into clinical trials...
news
Achilles’ heel of Ebola virus identified in new study
27 May 2015 | By Victoria White
An international team of scientists has identified the molecular “lock” that the deadly Ebola virus must pick to gain entry to cells...
news
Hemispherx Biopharma receives EMA Orphan Medicine Designation for Ampligen to treat Ebola
11 May 2015 | By Victoria White
Hemispherx Biopharma has received formal notification approving its Orphan Medicinal Product Application for Ampligen for the treatment of Ebola...
news
Inovio selected by DARPA to lead a team to expedite development of novel products to prevent and treat Ebola
8 April 2015 | By Victoria White
Inovio has been selected to receive a grant from DARPA to lead a collaborative team to develop multiple treatment and prevention approaches against Ebola...
news
Ebola: £1 million grant to develop ‘in the field’ test
27 March 2015 | By Victoria White
PHE scientists are heading a consortium researching a rapid ‘in the field’ Ebola test, following the successful award of IMI funding...
